MaxCyte, Inc.
Status: Publicly traded
Direct answer
MaxCyte, Inc. is publicly traded on NASDAQ under the ticker MXCT.
MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes cell therapeutics in the United States and internationally. The company's products consists of ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT...
Can you invest in MaxCyte, Inc.?
Yes. MaxCyte, Inc. is publicly traded on NASDAQ under the ticker MXCT.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for MaxCyte, Inc.
Detailed equity research is provided by MarketSnap.